Protective Effect of FTY720 Against Sevoflurane-Induced Developmental Neurotoxicity in Rats

Cell Biochemistry and Biophysics

Volumn 67, Issue 2, 2013, Pages 591-598

  Zhou, Hui ^a   Li, Song ^a   Niu, Xinhuan ^a   Wang, Ping ^a   Wang, Junnan ^a   Zhang, Mengyuan ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

ERK1 2; FTY720; Neurotoxicity; Sevoflurane

Indexed keywords

RATTUS;

DRUG DERIVATIVE; ETHER DERIVATIVE; FINGOLIMOD; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROPROTECTIVE AGENT; NEUROTOXIN; PROPANEDIOL DERIVATIVE; SEVOFLURANE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE RECEPTOR;

ANIMAL; APOPTOSIS; ARTICLE; CYTOLOGY; DRUG EFFECT; METABOLISM; NERVE CELL; PHOSPHORYLATION; RAT; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; APOPTOSIS; METHYL ETHERS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PHOSPHORYLATION; PROPYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LYSOSPHINGOLIPID; SPHINGOSINE; TIME FACTORS;

EID: 84886585956     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-013-9546-3     Document Type: Article

References (42)

1. Wilder, R. T., Flick, R. P., Sprung, J., Katusic, S. K., Barbaresi, W. J., Mickelson, C., et al. (2009). Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology, 110(4), 796-804.
2. Kalkman, C. J., Peelen, L., Moons, K. G., Veenhuizen, M., Bruens, M., Sinnema, G., et al. (2009). Behavior and development in children and age at the time of first anesthetic exposure. Anesthesiology, 110(4), 805-812.
3. Brambrink, A. M., Evers, A. S., Avidan, M. S., Farber, N. B., Smith, D. J., Zhang, X., et al. (2010). Isoflurane-induced neuroapoptosis in the neonatal rhesus macaque brain. Anesthesiology, 112(4), 834-841.
4. Edsall, L. C., Pirianov, G. G., & Spiegel, S. (1997). Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation. Journal of Neuroscience, 17(18), 6952-6960.
5. Shinpo, K., Kikuchi, S., Moriwaka, F., & Tashiro, K. (1999). Protective effects of the TNF-ceramide pathway against glutamate neurotoxicity on cultured mesencephalic neurons. Brain Research, 819(1-2), 170-173.
6. Edsall, L. C., Cuvillier, O., Twitty, S., Spiegel, S., & Milstien, S. (2001). Sphingosine kinase expression regulates apoptosis and caspase activation in PC12 cells. Journal of Neurochemistry, 76(5), 1573-1584.
7. Meng, H., Yuan, Y., & Lee, V. M. (2011). Loss of sphingosine kinase 1/S1P signaling impairs cell growth and survival of neurons and progenitor cells in the developing sensory ganglia. PLoS One, 6(11), e27150.
8. Czech, B., Pfeilschifter, W., Mazaheri-Omrani, N., Strobel, M. A., Kahles, T., Neumann-Haefelin, T., et al. (2009). The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia. Biochemical and Biophysical Research Communications, 389(2), 251-256.
9. Hasegawa, Y., Suzuki, H., Sozen, T., Rolland, W., & Zhang, J. H. (2010). Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke, 41(2), 368-374.
10. Rolland, II, W. B, Manaenko, A., Lekic, T., Hasegawa, Y., Ostrowski, R., Tang, J., et al. (2011). FTY720 is neuroprotective and improves functional outcomes after intracerebral hemorrhage in mice. Acta Neurochirurgica. Supplementum, 111, 213-217.
11. Wei, Y., Yemisci, M., Kim, H. H., Yung, L. M., Shin, H. K., Hwang, S. K., et al. (2011). Fingolimod provides long-term protection in rodent models of cerebral ischemia. Annals of Neurology, 69(1), 119-129.
12. Norimatsu, Y., Ohmori, T., Kimura, A., Madoiwa, S., Mimuro, J., Seichi, A., et al. (2012). FTY720 improves functional recovery after spinal cord injury by primarily nonimmunomodulatory mechanisms. American Journal of Pathology, 180(4), 1625-1635.
13. Vincent, A. M., & Maiese, K. (2000). The metabotropic glutamate system promotes neuronal survival through distinct pathways of programmed cell death. Experimental Neurology, 166(1), 65-82.
14. Lu, Y., Wu, X., Dong, Y., Xu, Z., Zhang, Y., & Xie, Z. (2010). Anesthetic sevoflurane causes neurotoxicity differently in neonatal naive and Alzheimer disease transgenic mice. Anesthesiology, 112(6), 1404-1416.
15. Sanders, R. D., Xu, J., Shu, Y., Januszewski, A., Halder, S., Fidalgo, A., et al. (2009). Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiology, 110(5), 1077-1085.
16. Wei, H., Kang, B., Wei, W., Liang, G., Meng, Q. C., Li, Y., et al. (2005). Isoflurane and sevoflurane affect cell survival and BCL-2/BAX ratio differently. Brain Research, 1037(1-2), 139-147.
17. Wakade, C., King, M. D., Laird, M. D., Alleyne, C. H, Jr, & Dhandapani, K. M. (2009). Curcumin attenuates vascular inflammation and cerebral vasospasm after subarachnoid hemorrhage in mice. Antioxidants & Redox Signaling, 11(1), 35-45.
18. Laird, M. D., Sukumari-Ramesh, S., Swift, A. E., Meiler, S. E., Vender, J. R., & Dhandapani, K. M. (2010). Curcumin attenuates cerebral edema following traumatic brain injury in mice: a possible role for aquaporin-4? Journal of Neurochemistry, 113(3), 637-648.
19. Biegon, A., Fry, P. A., Paden, C. M., Alexandrovich, A., Tsenter, J., & Shohami, E. (2004). Dynamic changes in N-methyl-D-aspartate receptors after closed head injury in mice: Implications for treatment of neurological and cognitive deficits. Proceedings of the National Academy of Sciences of the United States of America, 101(14), 5117-5122.
20. Oyama, Y., Chikahisa, L., Kanemaru, K., Nakata, M., Noguchi, S., Nagano, T., et al. (1998). Cytotoxic actions of FTY720, a novel immunosuppressant, on thymocytes and brain neurons dissociated from the rat. Japanese Journal of Pharmacology, 76(4), 377-385.
21. Foster, C. A., Howard, L. M., Schweitzer, A., Persohn, E., Hiestand, P. C., Balatoni, B., et al. (2007). Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis. Journal of Pharmacology and Experimental Therapeutics, 323(2), 469-475.
22. Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., et al. (2002). The immune modulator FTY720 targets sphingosine 1-phosphate receptors. Journal of Biological Chemistry, 277(24), 21453-21457.
23. Mullershausen, F., Craveiro, L. M., Shin, Y., Cortes-Cros, M., Bassilana, F., Osinde, M., et al. (2007). Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors. Journal of Neurochemistry, 102(4), 1151-1161.
24. Osinde, M., Mullershausen, F., & Dev, K. K. (2007). Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors. Neuropharmacology, 52(5), 1210-1218.
25. Zhang, Y., Dong, Y., Wu, X., Lu, Y., Xu, Z., Knapp, A., et al. (2010). The mitochondrial pathway of anesthetic isoflurane-induced apoptosis. Journal of Biological Chemistry, 285(6), 4025-4037.
26. Chiba, K. (2005). FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors. Pharmacology & Therapeutics, 108(3), 308-319.
27. Jevtovic-Todorovic, V., Hartman, R. E., Izumi, Y., Benshoff, N. D., Dikranian, K., Zorumski, C. F., et al. (2003). Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. Journal of Neuroscience, 23(3), 876-882.
28. Fanselow, M. S. (2000). Contextual fear, gestalt memories, and the hippocampus. Behavioural Brain Research, 110(1-2), 73-81.
29. Quinn, J. J., Loya, F., Ma, Q. D., & Fanselow, M. S. (2005). Dorsal hippocampus NMDA receptors differentially mediate trace and contextual fear conditioning. Hippocampus, 15(5), 665-674.
30. Wang, W. Y., Wang, H., Luo, Y., Jia, L. J., Zhao, J. N., Zhang, H. H., et al. (2012). The effects of metabotropic glutamate receptor 7 allosteric agonist N, N′-dibenzhydrylethane-1, 2-diamine dihydrochloride on developmental sevoflurane neurotoxicity: role of extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase signaling pathway. Neuroscience, 205, 167-177.
31. Stessin, A. M., Gursel, D. B., Schwartz, A., Parashar, B., Kulidzhanov, F. G., Sabbas, A. M., et al. (2012). FTY720, sphingosine 1-phosphate receptor modulator, selectively radioprotects hippocampal neural stem cells. Neuroscience Letters, 516(2), 253-258.
32. Jung, C. G., Kim, H. J., Miron, V. E., Cook, S., Kennedy, T. E., Foster, C. A., et al. (2007). Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells. Glia, 55(16), 1656-1667.
33. Postma, F. R., Jalink, K., Hengeveld, T., & Moolenaar, W. H. (1996). Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: action through a specific cell surface receptor. EMBO Journal, 15(10), 2388-2392.
34. Toman, R. E., Payne, S. G., Watterson, K. R., Maceyka, M., Lee, N. H., Milstien, S., et al. (2004). Differential transactivation of sphingosine-1-phosphate receptors modulates NGF-induced neurite extension. Journal of Cell Biology, 166(3), 381-392.
35. Sato, K., Tomura, H., Igarashi, Y., Ui, M., & Okajima, F. (1997). Exogenous sphingosine 1-phosphate induces neurite retraction possibly through a cell surface receptor in PC12 cells. Biochemical and Biophysical Research Communications, 240(2), 329-334.
36. Miron, V. E., Schubart, A., & Antel, J. P. (2008). Central nervous system-directed effects of FTY720 (fingolimod). Journal of the Neurological Sciences, 274(1-2), 13-17.
37. Straiko, M. M., Young, C., Cattano, D., Creeley, C. E., Wang, H., Smith, D. J., et al. (2009). Lithium protects against anesthesia-induced developmental neuroapoptosis. Anesthesiology, 110(4), 862-868.
38. Wang, Z., Shen, J., Wang, J., Lu, T., Li, C., Zhang, X., et al. (2012). Lithium attenuates bupivacaine-induced neurotoxicity in vitro through phosphatidylinositol-3-kinase/threonine-serine protein kinase B- and extracellular signal-regulated kinase-dependent mechanisms. Neuroscience, 206, 190-200.
39. Mawhinney, L. J., de Rivero Vaccari, J. P., Alonso, O. F., Jimenez, C. A., Furones, C., Moreno, W. J., et al. (2012). Isoflurane/nitrous oxide anesthesia induces increases in NMDA receptor subunit NR2B protein expression in the aged rat brain. Brain Research, 1431, 23-34.
40. Fredriksson, A., Ponten, E., Gordh, T., & Eriksson, P. (2007). Neonatal exposure to a combination of N-methyl-d-aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits. Anesthesiology, 107(3), 427-436.
41. Deogracias, R., Klein, C., Matsumoto, T., Yazdani, M., Bibel, M., & Barde, Y. (2008). Expression of brain-derived neurotrophic factor is regulated by FTY720 in cultured neurons. Multiple Sclerosis, 14, S243.
42. Coelho, R. P., Payne, S. G., Bittman, R., Spiegel, S., & Sato-Bigbee, C. (2007). The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors. Journal of Pharmacology and Experimental Therapeutics, 323(2), 626-635.